Posted by Michael Wonder on 06 Sep 2024
Azurity Pharmaceuticals announces FDA approval of Nymalize (nimodipine) oral solution 30 mg/5 mL pre-filled ENFit syringe
3 September 2024 - Azurity Pharmaceuticals announced today that the US FDA has approved Nymalize (nimodipine) oral solution in a 30 mg/5 mL pre-filled ENFit syringe.
The Nymalize 30 mg/5 mL pre-filled ENFit syringe may provide an additional layer of security for patients and health care professionals administering medication. ENFit connectors are recommended by the FDA and widespread adoption of ENFit has begun to replace traditional nasogastric tubing.
